N-(3-((5-chloro-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)acrylamide,
WZ-4002,
WZ4002,
WZ4002,
1213269-23-8,
WZ-4002,
N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide,
WZ 4002,
UNII-6BQ432Z61M,
CHEBI:61400,
CHEMBL1229592,
6BQ432Z61M,
N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide,
N-[3-[[5-Chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-2-propenamide,
N-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide,
SMR001913510,
SCHEMBL93699,
MLS003230945,
MLS006011213,
GTPL9176,
QCR-55,
CTK4B2311,
DTXSID30153230,
EX-A416,
HMS3265O15,
HMS3265O16,
HMS3265P15,
HMS3265P16,
HMS3654C16,
BCP02515,
KS-00000T9M,
ABP000892,
BDBM50383274,
s1173,
ZINC52509385,
AKOS025401946,
CS-0167,
RL00923,
SB19360,
NCGC00263144-01,
NCGC00263144-02,
NCGC00263144-11,
AC-27472,
AK186845,
AS-19387,
BC659932,
DA-47168,
HY-12026,
SC-95559,
AB0033756,
WZ4002, >=98% (HPLC),
FT-0730384,
SW219315-1,
X7482,
EC-000.2280,
S-7689,
J-004480,
J-523322,
WZ4002 , WZ 4002, 213269-23-8,
N-(3-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)acrylamide,
N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazine-1-yl)phenylamino)pyrimidin-4yloxy)phenyl)acrylam,
D0NJ3Q,
C25H27ClN6O3,
cc-192,
ITTRLTNMFYIYPA-UHFFFAOYSA-N,
ACN-031534,
WZ-3146,
WZ-8040,
A1389,
EGFR-T790M kinase inhibitors (lung cancer),
A10991,
C571455,
EGFR-T790M kinase inhibitors (lung cancer), Gatekeeper Pharmaceuticals,
2-Propenamide, N-[3-[[5-chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-,
N-(3-((5-chloro-2-((2-methoxy-4-(4-methyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)oxy)phenyl)acrylamide,